Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of hemoglobinopathies
3.2.1.2 Advancement in diagnostic technologies
3.2.1.3 Emerging gene therapies and stem cell transplantation
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost associated with treatment
3.2.2.2 Side effects associated with treatment
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Pipeline analysis
3.6 Future market trends
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Disease Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Thalassemia
5.2.1 Alpha thalassemia
5.2.2 Beta thalassemia
5.3 Sickle cell disease
5.4 Other disease types
Chapter 6 Market Estimates and Forecast, By Treatment, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Blood transfusion
6.3 Hydroxyurea
6.4 Iron chelation therapy
6.5 Bone marrow transplant
6.6 Other treatment types
Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Specialty clinics
7.4 Other end users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
Chapter 9 Company Profiles
9.1 bluebird bio
9.2 Bristol-Myers Squibb Company
9.3 CHIESI FARMACEUTICI
9.4 Emmaus Medical
9.5 Medunik USA
9.6 Novartis
9.7 Pfizer
9.8 Prolong Pharmaceuticals
9.9 Teva Pharmaceuticals Industries
9.10 Vertex Pharmaceuticals Incorporated
